Author： Viallet François Pitel Séverine Lancrenon Sylvie Blin Olivier
Publisher： Informa Healthcare
ISSN： 1473-4877
Source： Current Medical Research and Opinion, Vol.29, Iss.1, 2013-01, pp. : 23-31
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Rasagiline for the management of Parkinson’’s disease
By Dashtipour Khashayar Chen Jack J Lew Mark F
Therapy, Vol. 5, Iss. 2, 2008-03 ,pp. :
Access to resources
Recommend
Rasagiline for the symptomatic treatment of fatigue in Parkinson's disease
MOVEMENT DISORDERS, Vol. 30, Iss. 13, 2015-11 ,pp. :
Lesioning the Subthalamic Nucleus in the Treatment of Parkinson’s Disease
Stereotactic and Functional Neurosurgery, Vol. 77, Iss. 1-4, 2002-10 ,pp. :
Selegiline orally disintegrating tablet in the treatment of Parkinson’’s disease
By Clarke Anthony Jankovic Joseph
Therapy, Vol. 3, Iss. 3, 2006-05 ,pp. :